GPhA’s Goals For 2013: Smooth GDUFA Implementation, Workable Biosimilar Pathway

The generic drug trade association’s cross-cutting priorities are the result of an extensive strategic planning process, CEO Ralph Neas says; the group is planning outreach to Congress and the executive branch to highlight the role generic drugs can play in helping to address the nation’s fiscal problems.